Common Contracts

5 similar Merger Agreement contracts by Emcore Corp, Patriot Transportation Holding, Inc., Halozyme Therapeutics, Inc.

AGREEMENT AND PLAN OF MERGER by and among VELOCITY ONE HOLDINGS, LP AEROSPHERE POWER INC., VELOCITY MERGER SUB, INC. and EMCORE CORPORATION Dated as of November 7, 2024
Merger Agreement • November 8th, 2024 • Emcore Corp • Semiconductors & related devices • Delaware

This AGREEMENT AND PLAN OF MERGER, dated as of November 7, 2024 (this “Agreement”), is made by and among Velocity One Holdings, LP a Delaware limited partnership (“Parent”), Aerosphere Power Inc., a New Jersey corporation that, at the Effective Time will be an indirect wholly owned subsidiary of Parent (“Parent Group Member”), Velocity Merger Sub, Inc., a New Jersey corporation that, at the Effective Time will be an indirect wholly owned subsidiary of Parent (“Merger Sub”), and EMCORE Corporation, a New Jersey corporation (the “Company”). All capitalized terms used in this Agreement shall have the meanings assigned to such terms in Section ‎8.3 or as otherwise defined elsewhere in this Agreement unless the context clearly indicates otherwise.

AGREEMENT AND PLAN OF MERGER by and among VELOCITY ONE HOLDINGS, LP AEROSPHERE POWER INC., VELOCITY MERGER SUB, INC. and EMCORE CORPORATION Dated as of November 7, 2024
Merger Agreement • November 8th, 2024 • Emcore Corp • Semiconductors & related devices • Delaware

This AGREEMENT AND PLAN OF MERGER, dated as of November 7, 2024 (this “Agreement”), is made by and among Velocity One Holdings, LP a Delaware limited partnership (“Parent”), Aerosphere Power Inc., a New Jersey corporation that, at the Effective Time will be an indirect wholly owned subsidiary of Parent (“Parent Group Member”), Velocity Merger Sub, Inc., a New Jersey corporation that, at the Effective Time will be an indirect wholly owned subsidiary of Parent (“Merger Sub”), and EMCORE Corporation, a New Jersey corporation (the “Company”). All capitalized terms used in this Agreement shall have the meanings assigned to such terms in Section ‎8.3 or as otherwise defined elsewhere in this Agreement unless the context clearly indicates otherwise.

AGREEMENT AND PLAN OF MERGER
Merger Agreement • November 1st, 2023 • Patriot Transportation Holding, Inc. • Trucking & courier services (no air) • Florida

This AGREEMENT AND PLAN OF MERGER, dated as of November 1, 2023 (this “Agreement”), is made by and among Blue Horizon Partners, Inc., an Oklahoma corporation (“Parent”), Blue Horizon Partners Merger Sub, Inc., a Florida corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Patriot Transportation Holding, Inc., a Florida corporation (the “Company”). All capitalized terms used in this Agreement shall have the meanings assigned to such terms in Section 8.1 or as otherwise defined elsewhere in this Agreement unless the context clearly indicates otherwise.

AGREEMENT AND PLAN OF MERGER
Merger Agreement • November 1st, 2023 • Patriot Transportation Holding, Inc. • Trucking & courier services (no air) • Florida

This AGREEMENT AND PLAN OF MERGER, dated as of November 1, 2023 (this “Agreement”), is made by and among Blue Horizon Partners, Inc., an Oklahoma corporation (“Parent”), Blue Horizon Partners Merger Sub, Inc., a Florida corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Patriot Transportation Holding, Inc., a Florida corporation (the “Company”). All capitalized terms used in this Agreement shall have the meanings assigned to such terms in Section 8.1 or as otherwise defined elsewhere in this Agreement unless the context clearly indicates otherwise.

AGREEMENT AND PLAN OF MERGER among HALOZYME THERAPEUTICS, INC., ATLAS MERGER SUB, INC. and ANTARES PHARMA, INC. Dated as of April 12, 2022
Merger Agreement • April 13th, 2022 • Halozyme Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

THIS AGREEMENT AND PLAN OF MERGER is made and entered into as of April 12, 2022, by and among Halozyme Therapeutics, Inc., a Delaware corporation (“Parent”), Atlas Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and Antares Pharma, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.